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Purpose. With the FDA approval of thoracic endografts, extra-anatomic reconstruction of the aortic arch has allowed for
more suitable proximal landing zones and increased applicability of thoracic endovascular procedures. We evaluated our
short term and long term results of extra-anatomic reconstruction of the carotid and subclavian vessels.
Methods. One hundred and forty three (143) procedures were performed for extra-anatomic carotid and subclavian recon-
struction. Of these 143 operations: 85 were carotid subclavian reconstructions, 22 were carotid crossover bypasses, 30 were
subclavian carotid reconstructions and 6 were carotid subclavian transpositions. Sixty (42%) were male, 20 (14%) were
diabetic, and 63 (44%) were current smokers. Mean age was 63 (SD þ/ 12.3). Indication for surgery was primarily for
occlusive or embolic disease (97%). In those patients undergoing bypass graft, prosthetic (ePTFE) was used in 93%. Fol-
low-up was performed at 3 and 6 month intervals by ultrasound and pulse volume recordings where indicated. Life table
analyses were used to analyze patency.
Results. Of the 143 reconstructions operative mortality was 1 (0.7%). Non-fatal complications included 3 (2.1%) for
bleeding, 1 (0.7%) wound infection, 2 (1.4%) TIA, 1 (0.7%) suffered a non-fatal stroke, 2 (1.4%) had postoperative myo-
cardial infarctions, and 6 (4.3%) late (>30-day) occlusions. Follow-up was 1 to 124 months (mean: 39 months). Primary
patency at 1 year was 98%, 3 years 96%, and 5 years was 92%.
Conclusion. Extra-anatomic arch reconstruction can be performed safely and appears to be durable over long term follow-
up. Its use with endovascular grafting should provide a durable reconstruction for patients who require aortic ‘‘debranch-
ing’’ prior endovascular thoracic aortic aneurysm repair.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Extra-thoracic reconstruction of the aortic arch is per-
formed infrequently. It has been largely superseded
by endovascular treatment.1e3 It is perceived as diffi-
cult surgery, best avoided if possible. Exposure of the
subclavian artery has been described as a ‘‘notoriously
treacherous’’ by one author.4 With the advent of tho-
racic aneurysm repair, however, there has been a re-
vival of these operations in order to ‘debranch’ the
aortic arch and allow for a longer proximal landing
zone for stent grafts.5e7 Our experience with elective
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large. It should be a reference point for patients under-
going aortic debranching prior to thoracic stent-graft
insertion and also for the minority of patients with ath-
erosclerosis who still require open reconstructions.
In this study, we report the durability of extra-
thoracic reconstructions in our centre and on the conse-
quences of failure. We also describe the frequency of
procedures performed over time. As many older and
frailer patients undergo hybrid procedures in the tho-
racic aorta, we investigated if age affected outcomes
for supra-aortic reconstructions.We confined this study
to thoseundergoingextra-thoracicprocedures, bothby-
passes and transpositions, but did not include patients
who underwent innominate artery-based reconstruc-
tions requiring a median sternotomy or thoracotomy.
As this was a retrospective review of our group’s expe-
rience over a long period, no attempt was made tolar Surgery. Published by Elsevier Ltd. All rights reserved.
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ing subclavian, innominate or carotid stenting.
Methods
The details of all patients undergoing extra-anatomic
carotid and subclavian reconstructions were retrieved
from our vascular registry for the 18 years from 1/1/
1988e1/31/2006. The indication for surgery was re-
corded. The inflow artery, outflow artery and conduit
were recorded. We analysed patient demographics
and risk factors for atherosclerosis. We deliberately
excluded the following patients: those undergoing ca-
rotid to internal carotid bypass, trauma patients and
those with advanced malignancies. All intra-operative
and post-operative complications were recorded. All
patients were followed up post-operatively by pulse
volume recordings (PVRs) with graft Duplex scans.
Patients were followed up at 3 months, 6 months
and 12 months initially and then 6 monthly after
that time.
Special note was made of any neurological events
within the first 30 days. For purposes of definition:
neurological events within the first 30 days persisting
longer than 24 hours were regarded as a stroke. No
attempt was made to differentiate between ‘major’
and ‘minor’ or ‘disabling’ and ‘non-disabling’ strokes.
Graft patency was assessed by serial Duplex scans per-
formed at each out-patient visit. Note was made of any
secondary interventions. Graft occlusion and its conse-
quences were recorded. We compared patency rates
for the three bypass grafts. We also compared out-
comes in patients 70 years and older with those in
younger patients.
Of note, during this time there were 6 left subcla-
vian to common carotid artery transpositions per-
formed which we included in our analyses.
Surgical techniques
Carotid-Carotid Bypass. All carotid-carotid bypasses
were performed under general anaesthesia and were
tunneled behind the pharynx, whenever possible.
This was usually only possible, however, in half the
cases due to technical factors such as difficulty in
safely mobilizing the pharynx and orientation of the
carotid arteries.
Carotid-subclavian and subclavian-carotid bypass. Fol-
lowing exposure of the subclavian (SA) and common
carotid (CCA) arteries, as described elsewhere,8 a by-
pass was then performed in an end-to-side fashion
with a 6mmor 8mmexpanded polytetrafluoroethylene(ePTFE) graft (W. L. Gore & Associates, Inc. Medical
Products Division, P.O. Box 2400, Flagstaff, Arizona
86003-2400, USA). The graft was usually tunneled un-
der the internal jugular vein. The graft-SA anastomosis
was usually constructed first. A clampwas then placed
on the proximal graft, and the anastomosis to the CCA
was constructed. The CCAwas mobilised so that once
two straight vascular clamps are placed and rotated an-
teriorly, the graft-CCA anastomosis could be per-
formed more easily. Once the bypass has been
completed, flow was restoreddfirst to the arm, then
to the proximal SA, and finally to the distal CCA, so
as to prevent cerebral emboli. Flow was assessed with
a pencil Doppler probe.
Statistical Analysis: Graft patency was estimated us-
ing standard life table analysis (Kaplan-Meier) tech-
niques. Patency was expressed in terms of primary
patency only.
Results
Patient demographics (See Fig. 1)
There were 143 elective extra-anatomic carotid and
subclavian reconstructions performed in our unit be-
tween 1/1/1988 and 31/1//2006. Of these: 85 were
carotid subclavian reconstructions, 22 were carotid
crossover bypasses, 30 were subclavian carotid recon-
structions and 6 were carotid subclavian transposi-
tions. Eighty three (58%) of our patients were female,
60 (42%) were male. The mean age for the entire group
was 63 (SD þ/ 12.3). The mean age of our male pa-
tients was 64 (SD þ/ 11.78) and 63 (SD ¼/12.65)
years for females. There was no significant difference
in age between males and females ( p¼NS). Reported
pre-operative atherosclerotic risk factors were:
diabetes mellitus e 20 (14.0%), current cigarette
smokers e 63 (44.1%), hypertension e 24 (16.8%) and
dyslipidemia 25 (17.5%).
Operative procedures
There were 143 procedures performed on 143 patients.
In ten patients, the conduit was reversed greater sa-
phenous vein. In the remaining 127, the conduit was
6 mm or 8 mm ePTFE. Dacron grafts were not used.
Vein diameter was not recorded.
The most common procedure was common carotid
to subclavian bypass which was performed in 85
(59.4%) patients: Left common carotid to subclavian
bypass was performed in 70 patients, and 15 under-
went a right common carotid to subclavian bypass. Of
these, 82 were performed using PTFE. The remainder
Eur J Vasc Endovasc Surg Vol 34, October 2007
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Fig. 1. Demographic data on 143 patients undergoing extra-anatomic procedures.were performed with greater saphenous vein. Thirty
patients (21%) underwent subclavian-carotid bypass:
24 using PTFE; 3 with vein. Twenty two patients
(15.4%) underwent common carotid -common carotid
bypass: 21 with PTFE and 1 with greater saphenous
vein. The remaining 6 (4.2%) patients underwent left
carotid-subclavian transpositions.
Operative indications by procedure
Carotid- Subclavian Bypass: The most frequent indi-
cations for the 85 carotid-subclavian bypasses were
symptomatic subclavian syndrome in 24 (28.2%), arm
claudication in 16 (18.8%), acute arterial thrombosis
in 15 (17.6%), critical ischaemia 8 (9.4%) and embolisa-
tion 6 (7.1%). Five patients (5.9%) underwent bypass
for coronary steal syndrome. Six patients (7.1%) under-
went bypass for aneurysmal disease and 1 (1.2%) for
thoracic outlet syndrome. Four patients (4.7%) pre-
sented with symptomatic posterior circulation events
(3 TIA, 1 stroke).
Subclavian-Carotid Bypass: Thirty subclavian-
carotid bypasses were performed from 1988e2005.
The most common indications were neurological,
comprising 20 out of 30 bypasses performed: transient
ischaemic attack 9 (30%), stroke 5 (16.7%), asymptom-
atic stenosis 5 (16.7%) and amaurosis fugax 1 (3.3%).
Tenpatients had other occlusions or embolic symptoms
(5 arterial thrombosis, 1 vertebrobasilar, 1 aneurysm, 1
claudication, 1 subclavian steal, 1 microembolic).
Carotid -Carotid Bypass: Twenty-two patients un-
derwent carotid-carotid bypass. As with subclavian-
carotid bypass, the majority were for neurological
Eur J Vasc Endovasc Surg Vol 34, October 2007indications: asymptomatic carotid stenosis 4 (18.2%),
transient ischaemic attack 5 (22.7%), amaurosis fugax
2 (9.1%), stroke 2 (9.1%) and vertebrobasilar symptoms
2 (9.1%). Seven patients (31.8%) had asymptomatic
common carotid artery obstruction with a patent ICA.
Carotid-Subclavian Transpositions. Six patients
underwent carotid subclavian transpositions for
symptomatic left subclavian artery occlusive disease.
There were no deaths and no strokes in this group
and no post-operative complications. No occlusions
occurred. There were three deaths in the follow up pe-
riod in these patients, at 11, 37 and 62 months follow-
ing surgery not related to their vascular surgery. The
remaining patients remain alive with functioning
transpositions.
Operative morbidity and mortality (See Table 1)
There was one (0.7%) operative mortality. This was
a fatal myocardial infarction which occurred on
post-operative day three in a 71 year old man
Table 1. Post-operative complications for all 143 procedures
Complication Number (%)
Operative Deaths 1 (0.7%)
Bleeding 3 (2.1%)
Wound Infections 1 (0.7%)
Neurological 3 (2.1%)
TIA 2 (1.4%)
non-fatal stroke 1 (0.7%)
Non-fatal myocardial infarctions 2 (1.4%)
Pulmonary complications 1 (0.7%)
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Non-fatal complications included 3 (2.1%) patients
who needed to return to the operating room for bleed-
ing and 1 (0.7%) patient sustained a wound infection.
Neurological complications occurred in 3 (2.1%)
patients: 2 (1.4%) patients had TIAs and 1 (0.7%)
suffered a non-fatal stroke but ultimately died of
pulmonary complications two months after surgery.
Two patients (1.4%) had non-fatal postoperative myo-
cardial infarctions and one had serious pulmonary
complications, but ultimately recovered. There were
no major nerve injuries.
Long-term outcome (See Table 2 and Fig. 3)
Follow-up was 1 to 124 months (mean: 39 months).
Primary patency for all reconstructions at 1 year was
98%, 3 years 96%, and 5 years was 92% (See Fig. 2).
There were 6 (4.3%) late (>30-day) occlusions. In 3
of these patients, the occlusions were asymptomatic.
In two patients, occlusion of a carotid-subclavian by-
pass resulted in arm ischaemia. Another patient sus-
tained an occlusion of his subclavian-carotid bypass
and suffered a transient ischaemic attack. There
were no significant differences in patency rates for
the three bypasses studied (See Fig. 3).
Results of re-do surgery
Following graft occlusion, three patents (2.1%) under-
went secondary procedures. Two patients had re-do
carotid-subclavian bypasses. These remained patent
for 47 and 64 months respectively. The patient in
whom the subclavian-carotid bypass occluded under-
went a carotid-carotid crossover bypass to restoreflow through the affected carotid territory. This
bypass remains open at 151 months.
Outcomes in patients over 70 years (See Table 3)
Fifty-one patients were 70 years or older at time of
surgery. Of these: one died from a myocardial infarc-
tion, two had bleeding complications. One had
a stroke and died two months later. Patency rates
were not significantly different to those patients under
70 undergoing bypass.
Time trends in performance of extra-thoracic
operations (See Fig. 4)
At the outset of the study period, there were few
extra-thoracic bypass operations performed. However,
from 1996 to the present, a mean of 12 (SD ¼/4.05)
procedures per annum were performed in our unit.
We do not have accurate data for the number of sub-
clavian artery stents performed in our area due to
the fragmented nature of endovascular interventions
in the area served by our surgical group.
Discussion
In our centre, the majority of patients with subclavian
stenoses and proximal common carotid artery lesions
Table 2. Consequences of graft failure
Patient Bypass Months Symptoms
1. Carotid-subclavian 47 Arm ischaemia
2. Subclavian-Carotid 8 TIA
3. Carotid-subclavian 30 None
4. Carotid-subclavian 38 None
5. Carotid-subclavian 64 None
6. Carotid-subclavian 6 Arm ischaemia0
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Fig. 2. Cumulative primary patency for all 143 aortic extra-anatomic bypass reconstructions.
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Fig. 3. Cumulative patency rates for carotid-subclavian, carotid-carotid and subclavian-carotid bypasses. Carotid-subclavian
transpositions not included due to small numbers. C-S¼ carotid subclavian; C-C¼ carotid-carotid; S-C¼ subclavian-carotid.are now treated by balloon angioplasty and stent inser-
tion. We now use hybrid procedures for the manage-
ment of difficult thoracic aneurysms. As a result,
extra-anatomic bypass is experiencing a revival due
to the need to expand potential landing zones or prox-
imal fixation sites for thoracic endografts. In many
units, extra-anatomic bypass is rarely performed due
to the adoption of subclavian artery angioplasty and
stenting for atherosclerosis of the supra-aortic
branches. As a result, large contemporary series are
few.9e11Our experience of 143 extra-anatomic bypasses
is large and compareswith the largest contemporary re-
ports. In this study, we review a single centre’s out-
comes. We deliberately did not compare these results
with more contemporary results in our centre from en-
dovascular stenting of carotid or subclavian lesions for
two reasons: First, we felt such comparisons would be
Table 3. Comparison of outcomes in Patients 70 years and older
and those less than 70 years at time of surgery
Age less than 70 years 70 years and over
Number 86 51
Deaths 0 1
Major Morbidities
Bleeding 1 2
Non-fatal Stroke 0 1
TIA 2 0
Non-fatal MI 1 1
Renal 1 0
Wound infection 1 0
Eur J Vasc Endovasc Surg Vol 34, October 2007unsound and secondly, we are aware that a large num-
ber of vascular interventions in our catchment area are
now performed by independent radiology groups or
interventional cardiologists, further complicating data
collection and interpretation. We rarely perform ax-
illo-axillary bypass for subclavian artery occlusions
due to its poor long term patency and high incidence
of recurrent symptoms. This study instead should be
regarded as a benchmark against which endovascular
interventionsmay bemeasured.All bypasseswere per-
formed using ePTFE grafts. This is our preferred pros-
thetic material. We use it for all elective reconstructions
including elective and ruptured abdominal aortic an-
eurysm repair.
Takach and his colleagues from Houston9 have
shown that transthoracic approaches to the arch vessels
can be achieved with a morbidity and mortality equal
to extrathoracic reconstruction. However, it is notewor-
thy that the mean age of their patients undergoing
transthoracic procedures was 54 years compared to
63 years for our patients. The Houston group also com-
pared outcomes for carotid subclavian bypass in 229
patients with those for 162 patients undergoing stent-
ing.10While both had good outcomes, extrathoracic by-
pass had significantly better mid-term freedom from
failure than endovascular intervention with excellent
long-term durability. The main benefits of en-
dovascular therapy were found in lower cost and
subjective patient satisfaction. Certainly, the results
from this series would support the argument that
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Fig. 4. Time trend in number of procedures performed 1988e2006.extra-thoracic bypasses are durable and rarely require
re-intervention: Our mean follow-up was 39 months,
five year patency was over 90% and only three patients
(2%) required revision of their grafts. Extra-thoracic
bypasswas also compared to stenting by the St Thomas’
group in the United Kingdom11 who reported a second-
ary 5 year patency rate of 97% for surgical bypass but
only an 81% four-year patency rate for stenting.
As expected, we found no differences in patency
rates between the three bypass grafts studied. We
also demonstrated that the associated operative mor-
bidities are low and that the apprehension many
have about these bypasses is probably based on anec-
dotal reports rather than real evidence.
These bypasses were also tolerated in elderly pa-
tients (>70 years) who may have most to gain from
endovascular stenting, given the large mortality rates
attached to open surgery in this age group, even in the
hands of experts. In our experience, there was no dif-
ference in outcome between our younger patients and
the septuagenarians and octogenarians who under-
went surgery.
It was interesting to see the trends in performance
of these operations. We would have predicted that
there would have been a normal distribution in the
number of procedures performed. However, after
1996, the number of procedures remained at a rela-
tively constant 12 per annum.
We were also curious about the consequences of
graft failure, given our relatively large study popula-
tion and long duration of follow-up. For those six pa-
tients who had late occlusions, three of them were
asymptomatic with no reports of arm ischaemia or
vertebro-basilar insufficiency. Two had arm ischae-
mia, however, and one suffered a TIA. This indicated
that while failure of extra-anatomic bypass of theaortic arch is rare, when it occurs, it often causes little
morbidity. Only three of our patients with late occlu-
sions needed revision surgery.
In the endovascular era, when stenting, being less
invasive, is taken as the gold standard in the manage-
ment of supra-thoracic occlusive disease, it is worth
revisiting the results of surgery. It deserves remember-
ing that bypass surgery is durable and can be per-
formed with minimal morbidity and mortality.
These results should be used as a benchmark against
which endovascular therapy ought to be compared.
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